The Association between Fetal Growth Restriction and Maternal Morbidity

Abstract

Objective This study aimed to compare adverse maternal outcomes between pregnancies complicated by fetal growth restriction (FGR) and those without FGR.

Study Design This was a secondary analysis of the data from the Consortium on Safe Labor, which was conducted from 2002 to 2008 in 12 clinical centers with 19 hospitals across 9 American College of Obstetricians and Gynecologists districts. We included singleton pregnancies without any maternal comorbidities or placenta abnormalities. We compared the outcomes of individuals with FGR with individuals without FGR. Our primary outcome was severe maternal morbidity. Our secondary outcome included various adverse maternal and neonatal outcomes. Multivariable logistic regression was performed to obtain adjusted odds ratios (aOR) and 95% confidence intervals (95% CI), adjusting for confounders. Missing values for maternal age and body mass index were imputed.

Results Of 199,611 individuals, 4,554 (2.3%) had FGR and 195,057 (97.7%) did not have FGR. Compared with the individuals without FGR, individuals with FGR had increased odds of severe maternal morbidity (0.6 vs. 1.3%; aOR: 1.97 [95% CI: 1.51–2.57]), cesarean delivery (27.7 vs. 41.2%; aOR: 2.31 [95% CI: 2.16–2.48]), pregnancy-associated hypertension (8.3 vs. 19.2%; aOR: 2.76 [95% CI: 2.55–2.99]), preeclampsia without severe features (3.2 vs. 4.7%; aOR: 1.45 [95% CI: 1.26–1.68]), preeclampsia with severe features (1.4 vs. 8.6%; aOR: 6.04 [95% CI: 5.39–6.76]), superimposed preeclampsia (18.3 vs. 30.2%; aOR: 1.99 [95% CI: 1.53–2.59]), neonatal intensive care unit admission (9.7 vs. 28.4%; aOR: 3.53 [95% CI: 3.28–3.8]), respiratory distress syndrome (2.2 vs. 7.7%; aOR: 3.57 [95% CI: 3.15–4.04]), transient tachypnea of the newborn (3.3 vs. 5.4%; aOR: 1.62 [95% CI: 1.40–1.87]), and neonatal sepsis (2.1 vs. 5.5%; aOR: 2.43 [95% CI: 2.10–2.80]).

Conclusion FGR was associated with increased odds of severe maternal outcomes in addition to adverse neonatal outcomes.

Key Points

• FGR is associated with cesarean section.

• FGR is not associated with severe maternal morbidity.

• FGR is related to pregnancy-associated hypertension.

• FGR is associated with neonatal morbidity.

Keywords

fetal growth restriction - neonatal morbidity - severe maternal morbidity - small for gestational age

Notes

Institutions involved in the CSL include, in alphabetical order: Baystate Medical Center, Springfield, MA; Cedars-Sinai Medical Center Burnes Allen Research Center, Los Angeles, CA; Christiana Care Health System, Newark, DE; Georgetown University Hospital, MedStar Health, Washington, DC; Indiana University Clarian Health, Indianapolis, IN; Intermountain Healthcare and the University of Utah, Salt Lake City, UT; Maimonides Medical Center, Brooklyn, NY; MetroHealth Medical Center, Cleveland, OH; Summa Health System, Akron City Hospital, Akron, OH; The EMMES Corporation, Rockville, MD (Data Coordinating Center); University of Illinois at Chicago, Chicago, IL; University of Miami, Miami, FL; and University of Texas Health Science Center at Houston, Houston, TX. The named authors alone are responsible for the views expressed in this manuscript, which does not necessarily represent the decisions or the stated policy of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Principal Investigator: T.S.

Publikationsverlauf

Eingereicht: 24. März 2022

Angenommen: 23. Mai 2023

Artikel online veröffentlicht:
26. Juni 2023

• References

• 1 Unterscheider J, O'Donoghue K, Daly S. et al. Fetal growth restriction and the risk of perinatal mortality-case studies from the multicentre PORTO study. BMC Pregnancy Childbirth 2014; 14: 63-63
• 2 Saleem T, Sajjad N, Fatima S, Habib N, Ali SR, Qadir M. Intrauterine growth retardation–small events, big consequences. Ital J Pediatr 2011; 37 (01) 41
• 3 Zhang Q, Zhang C, Wang Y. et al. Relationship of maternal obesity and vitamin D concentrations with fetal growth in early pregnancy. Eur J Nutr 2022; 61 (02) 915-924
• 4 Eleftheriades M, Creatsas G, Nicolaides K. Fetal growth restriction and postnatal development. Ann N Y Acad Sci 2006; 1092 (01) 319-330
• 5 Burton GJ, Yung HW, Cindrova-Davies T, Charnock-Jones DS. Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 2009; 30 (suppl, suppl A): S43-S48
• 6 Lees C, Marlow N, Arabin B. et al; TRUFFLE Group. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol 2013; 42 (04) 400-408
• 7 Zhang J, Troendle J, Reddy UM. et al; Consortium on Safe Labor. Contemporary cesarean delivery practice in the United States. Am J Obstet Gynecol 2010; 203 (04) 326.e1-326.e10
• 8 Martins JG, Biggio JR, Abuhamad A. Society for Maternal-Fetal Medicine consult series #52: diagnosis and management of fetal growth restriction: (replaces clinical guideline number 3, April 2012). Am J Obstet Gynecol 2020; 223 (04) B2-B17
• 9 Maternal mortality rates in the United States, 2020. Centers for Disease Control and Prevention. February 23, 2022. Accessed March 20, 2023 at: https://www.cdc.gov/nchs/data/hestat/maternal-mortality/2020/maternal-mortality-rates-2020.htm#:~:text=The%20maternal%20mortality%20rate%20for,(Figure%201%20and%20Table)
• 10 Main EK, Abreo A, McNulty J. et al. Measuring severe maternal morbidity: validation of potential measures. Am J Obstet Gynecol 2016; 214 (05) 643.e1-643.e10
• 11 Himes KP, Bodnar LM. Validation of criteria to identify severe maternal morbidity. Paediatr Perinat Epidemiol 2020; 34 (04) 408-415
• 12 Jha K, Nassar GN, Makker K. Transient Tachypnea of the Newborn. In: StatPearls. Treasure Island (FL): StatPearls Publishing; ; July 5, 2022
• 13 Yadav S, Lee B, Kamity R. Neonatal Respiratory Distress Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 25, 2022
• 14 Centers for Disease Control and Prevention. Severe morbidity indicators and corresponding ICD-9-CM/ICD-10-CM/PCS Codes during delivery hospitalizations 2019
• 15 Balogun OA, Khanagura RK, Kregel HR, Amro FH, Sibai BM, Chauhan SP. Preterm preeclampsia with severe features: composite maternal and neonatal morbidities associated with fetal growth restriction. Am J Perinatol 2018; 35 (08) 785-790
• 16 Mecacci F, Avagliano L, Lisi F. et al. Fetal growth restriction: does an integrated maternal hemodynamic-placental model fit better?. Reprod Sci 2021; 28 (09) 2422-2435
• 17 Foo FL, Mahendru AA, Masini G. et al. Association between prepregnancy cardiovascular function and subsequent preeclampsia or fetal growth restriction. Hypertension 2018; 72 (02) 442-450
• 18 Mitani M, Matsuda Y, Makino Y, Akizawa Y, Ohta H. Clinical features of fetal growth restriction complicated later by preeclampsia. J Obstet Gynaecol Res 2009; 35 (05) 882-887
• 19 Reddy UM, Rice MM, Grobman WA. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Serious maternal complications after early preterm delivery (24-33 weeks' gestation). Am J Obstet Gynecol 2015; 213 (04) 538.e1-538.e9
• 20 Blanc J, Rességuier N, Loundou A. et al. Severe maternal morbidity in preterm cesarean delivery: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2021; 261: 116-123
• 21 American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. Female sexual dysfunction: ACOG practice bulletin clinical management guidelines for obstetrician-gynecologists, number 213. Obstet Gynecol 2019; 134 (01) e1-e18
• 22 American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 227: fetal growth restriction. Obstet Gynecol 2021; 137 (02) e16-e28